Precision Medicine & Functional Genomics 2025 (PMFG 2025)

Theme: Precision Medicine and the Future of Genomics
Dates: December 2025
Venue: Doha, Qatar
Format: Hybrid (In-person & Virtual)
CME/CPD: Accredited Group Learning Activity

Overview

Precision Medicine & Functional Genomics 2025 (PMFG 2025) marked another milestone in Sidra Medicine’s flagship precision medicine conference series. Building on more than a decade of regional leadership in genomics and translational science, PMFG 2025 brought together internationally recognized experts, clinicians, researchers, policymakers, and healthcare innovators to explore advances shaping the future of genomic medicine.

The conference focused on translating large-scale genomic discoveries into clinical implementation, with particular emphasis on population genomics, advanced diagnostics, innovative therapeutics, and artificial intelligence–enabled healthcare solutions. PMFG 2025 reinforced Sidra Medicine’s commitment to advancing precision medicine for women and children in Qatar, the region, and globally.

Conference Themes

PMFG 2025 was structured around strategic pillars aligned with Sidra Medicine’s precision medicine mission:

Population & Newborn Genomics – Expanding genomic screening initiatives and integrating population-scale data into clinical workflows.
Precision Diagnostics – Multi-omics technologies and biomarker discovery to improve diagnosis of rare and complex diseases.
Next-Generation Therapeutics – Advances in gene therapy, genome editing, and personalized treatment strategies.
AI & Computational Biology – Machine learning applications in disease prediction, variant interpretation, and clinical decision support.
Maternal & Pediatric Precision Health – Translational innovation across reproductive, perinatal, and pediatric care.

Program Highlights

PMFG 2025 featured plenary lectures, scientific sessions, and multidisciplinary panel discussions addressing the evolving landscape of precision medicine.

Plenary Sessions

Internationally renowned keynote speakers presented cutting-edge developments in genomic medicine, population health programs, therapeutic innovation, and global implementation strategies.

Scientific Tracks

Dedicated sessions explored:

Genomic newborn screening and early detection frameworks
Rare disease gene discovery and clinical integration
Population cohort analysis and genomic diversity
Precision oncology and targeted therapies
Gene therapy and genome editing technologies
Ethical, regulatory, and policy considerations in genomic medicine

Masterclasses & Workshops

Specialized masterclasses provided in-depth exploration of:

Rare disease genomic analysis and variant interpretation
AI-driven approaches in healthcare and translational research
Clinical implementation models for precision medicine programs
Standards and best practices in genetic counseling

Distinguished Speakers

PMFG 2025 welcomed leading international experts in genomics, translational research, computational biology, and precision therapeutics from major academic institutions and healthcare systems worldwide.

Sidra Medicine faculty and national collaborators also presented pioneering research from Qatar’s expanding precision medicine ecosystem, highlighting advances in genomic screening, disease modeling, and personalized care delivery.

Learning Objectives & Accreditation

At the conclusion of PMFG 2025, participants were able to:

Evaluate recent advances in population and newborn genomic screening.
Discuss implementation strategies for integrating precision diagnostics into clinical care.
Identify emerging therapeutic approaches, including gene therapy and genome editing.
Assess ethical and regulatory considerations in genomic research and data governance.
Explore the role of artificial intelligence in predictive modeling and personalized medicine.

The conference was accredited as a Group Learning Activity and provided continuing medical education credits in accordance with national accreditation standards.

Scientific Impact

PMFG 2025 strengthened Qatar’s role as a regional hub for precision medicine by fostering multidisciplinary collaboration between clinicians, scientists, industry leaders, and policymakers. The conference showcased national genomic initiatives, facilitated international research partnerships, and supported early-career investigators through dedicated scientific platforms.

Through knowledge exchange and collaborative dialogue, PMFG 2025 advanced the integration of genomics into routine clinical care and reinforced Sidra Medicine’s leadership in precision medicine innovation.